- KMB +0.77% KVUE +0.75% JNJ -0.31%
Kimberly-Clark Corporation (NASDAQ:KMB) is included among the 15 Best Boring Dividend Stocks to Buy.
Analysts Note Stronger Outlook as Kimberly-Clark (KMB) Deepens Its Consumer Health Footprint On November 13, Argus analyst John Staszak upgraded Kimberly-Clark Corporation (NASDAQ:KMB) to a Buy rating from Hold and set a $120 price target, according to a report by The Fly. He pointed out that the stock has been lagging lately, but the company posted better-than-expected third quarter earnings and announced plans to acquire Kenvue, a deal expected to be completed in the second half of next year.
Kenvue became a standalone company a little over two years ago after separating from Johnson & Johnson. It focuses on consumer health and owns well-known brands such as Band-Aid, Johnson’s, Listerine, Neutrogena, Aveeno, and Tylenol. Both Kenvue and Kimberly-Clark Corporation (NASDAQ:KMB) operate in product categories that tend to remain resilient even in slower economic periods, which makes KMB an appealing value pick for long-term investors.
Kimberly-Clark Corporation (NASDAQ:KMB) earns most of its revenue through direct sales to retailers, distributors, and online platforms. The company has a broad global footprint serving both consumer and professional markets. Its customer base includes supermarkets, big-box stores, drugstores, warehouse clubs, and institutional buyers in areas such as manufacturing, hospitality, and public facilities.
While we acknowledge the potential of KMB as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 15 Best Long Term Stocks to Buy According to Reddit and 15 Best Stocks to Buy for Medium Term
Disclosure: None.
Terms and Privacy Policy Privacy Dashboard More Info
